The Power List 2018 – Business Captains
Executive Chairman and Co-Founder, Allogene Therapeutics
Arie has founded several successful biopharmaceutical companies, including Agensys, Cougar Biotechnology, and most recently Kite pharma, acquired by Gilead in 2017 for $12 billion dollars. In October last year, Kite Pharma’s Yescarta became the second CAR-T therapy approved by the FDA. And in April, 2018, Arie raised $300 to co-found Allogene Therapeutics, which will acquire and advance a portfolio of off-the-shelf CAR-T therapies previously controlled by Pfizer.